Publishing research using ab33515? Please let us know so that we can cite the reference in this datasheet.
ab33515 has been referenced in 1 publication.
Angell TE et al.MHC class I loss is a frequent mechanism of immune escape in papillary thyroid cancer that is reversed by interferon and selumetinib treatment in vitro.Clin Cancer Res 20:6034-44 (2014).
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"